Full Press Release Details
Bacterin Announces Earnings Release And
Conference Call Date
For 2012 Fourth Quarter & Year End Results
BELGRADE, MT - March 13, 2013 - Bacterin
International Holdings, Inc. (NYSE MKT: BONE), a leader in the development of revolutionary bone graft material and coatings for
medical applications, today announced that it will release its financial results for the period ended December 31, 2012, after
the close of U.S. financial markets on March 26, 2013.
An accompanying conference call hosted
by Guy Cook, Chief Executive Officer, and John Gandolfo, Chief Financial Officer, to discuss results will be held at 10:00 a.m.
ET, on Wednesday, March 27, 2013. Please refer to the information below for conference call dial-in information and webcast registration.
| Conference dial-in: | 877-269-7756 |
| International dial-in: | 201-689-7817 |
| Conference Name: | Bacterin's 2012 Fourth Quarter & Year End Results Conference Call |
| Webcast Registration: | Click Here |
Following the live call, a replay will
be available on the Company's website, www.bacterin.com, under "Investor Info".
About Bacterin International Holdings
Bacterin International Holdings, Inc. (NYSE
MKT: BONE) develops, manufactures and markets biologics products to domestic and international markets. Bacterin's proprietary
methods optimize the growth factors in human allografts to create the ideal stem cell scaffold to promote bone, subchondral repair
and dermal growth. These products are used in a variety of applications including enhancing fusion in spine surgery, relief of
back pain, promotion of bone growth in foot and ankle surgery, promotion of cranial healing following neurosurgery and subchondral
repair in knee and other joint surgeries.
Bacterin's Medical Device division develops,
employs, and licenses bioactive coatings for various medical device applications. For further information, please visit www.bacterin.com